REQUEST A DEMO
Total
USD $0.00
Search more companies

Filfarm OOO (Филфарм ООО) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Filfarm OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Filfarm OOO (Филфарм ООО) is a company in Russia, with a head office in Moscow. It operates in the Pharmacies and Drug Stores sector. The company was established on December 02, 2014. From the latest financial highlights, Filfarm OOO (Филфарм ООО) reported a net sales revenue drop of 28.07% in 2024. Its’ total assets recorded a negative growth of 99.1%. The net profit margin of Filfarm OOO (Филфарм ООО) decreased by 4.57% in 2024.

Headquarters
Pererva, 52, 209
Moscow; Moscow; Postal Code: 109341

Contact Details: Purchase the Filfarm OOO (Филфарм ООО) report to view the information.

Basic Information
Registered Capital:
Purchase the Filfarm OOO (Филфарм ООО) report to view the information.
Financial Auditors:
Purchase the Filfarm OOO (Филфарм ООО) report to view the information.
Incorporation Date:
December 02, 2014
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Filfarm OOO (Филфарм ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-28.07%
Total operating revenue
-28.07%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-98.91%
Total Assets
-99.1%
Total Equity
-98.11%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-4.57%
Return on Equity (ROE)
-42.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?